$1.90
2.70% yesterday
Nasdaq, May 19, 10:11 pm CET
ISIN
US7574681034
Symbol
RDHL
Sector
Industry

RedHill Biopharma Ltd. Sponsored ADR Stock price

$1.90
-0.27 12.44% 1M
-4.95 72.26% 6M
-4.31 69.40% YTD
-9.60 83.48% 1Y
-1,048.10 99.82% 3Y
-7,148.10 99.97% 5Y
-15,758.10 99.99% 10Y
Nasdaq, Closing price Mon, May 19 2025
+0.05 2.70%
ISIN
US7574681034
Symbol
RDHL
Sector
Industry

Key metrics

Market capitalization $2.42m
Enterprise Value $-11.45m
EV/FCF (TTM) EV/FCF 0.44
EV/Sales (TTM) EV/Sales -0.32
P/S ratio (TTM) P/S ratio 0.07
Short interest 3.61%

Is RedHill Biopharma Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

RedHill Biopharma Ltd. Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast RedHill Biopharma Ltd. Sponsored ADR:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast RedHill Biopharma Ltd. Sponsored ADR:

Buy
100%

Financial data from RedHill Biopharma Ltd. Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '23
+/-
%
36 36
56% 56%
100%
- Direct Costs 21 21
53% 53%
60%
14 14
59% 59%
40%
- Selling and Administrative Expenses 38 38
37% 37%
108%
- Research and Development Expense 5.04 5.04
69% 69%
14%
-29 -29
31% 31%
-83%
- Depreciation and Amortization 5.65 5.65
68% 68%
16%
EBIT (Operating Income) EBIT -35 -35
42% 42%
-99%
Net Profit 11 11
115% 115%
32%

In millions USD.

Don't miss a Thing! We will send you all news about RedHill Biopharma Ltd. Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RedHill Biopharma Ltd. Sponsored ADR Stock News

Neutral
PRNewsWire
7 days ago
Korea's Incheon District Court attachment grant prevents asset disposal by Kukbo prior to enforcement , following the New York Supreme Court's approximately $8.25 million plus legal fees and costs summary judgment in favor of RedHill -- The New York Supreme Court dismissed all Kukbo's counterclaims -- Latest Court victory demonstrates RedHill's commitment to collection of the court-mandated awa...
Neutral
PRNewsWire
18 days ago
RedHill supports an independent medical education grant that includes a new two-part H. Pylori Continuing Medical Education (CME) program, developed by Medscape aimed at advancing clinical knowledge and improving patient outcomes -- The first part of the program, led by a faculty of William Chey, MD, Vivian Asamoah, MD and Shailja Shah, MD, MPH, will take place May 6 during a major U.S. gastroe...
Neutral
PRNewsWire
22 days ago
Strong Use of Composition-of-Matter Coverage: Patent protects the molecular structure of RHB-107, providing market exclusivity beyond method-of-use claims COVID-19 Therapeutic Use: Includes coverage for treatment of SARS-CoV-2, including wild-type and emerging variants This patent grant enhances RedHill's strategic positioning in the global COVID-19 therapeutic space, a market still expected to...
More RedHill Biopharma Ltd. Sponsored ADR News

Company Profile

RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Head office Israel
CEO Dror Ben-Asher
Founded 2009
Website www.redhillbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today